MM

Mark Adelman, MD

Chief Medical Officer at Syntactx

Mark Adelman, MD has extensive work experience in the field of vascular surgery. Mark is currently serving as the Associate Program Director and a member of the Advisory Board at VEITHsymposium since January 2021. Prior to this, they held the position of Chief Medical Officer and Managing Clinical Director at Syntactx from December 2018 and June 2019 respectively.

Dr. Adelman has a long-standing association with NYU Langone Health, where they served as a Tenured Professor and Chief of Vascular and Endovascular Surgery from March 2006 to April 2018. During their tenure, they demonstrated expertise in both clinical and basic science research in vascular surgery, as well as inpatient and outpatient clinical vascular surgery. Mark also utilized their skills in business administration within the academic vascular surgery field.

Dr. Adelman's career in medicine began at NYU School of Medicine in July 1991, where they earned their MD degree. Mark continued their association with NYU until April 2018, holding various roles during this time.

Overall, Mark Adelman, MD has a diverse and accomplished work history, with a focus on vascular surgery and its multidimensional aspects.

Mark Adelman, MD obtained their Bachelor's degree in Biology, General from the University of Virginia, where they attended from 1977 to 1981. Following this, they pursued their Doctor of Medicine (M.D.) from New York University, specializing in the Vascular Surgery Residency Program. Mark completed their medical education at New York University from 1981 to 1985.

Links

Timeline

  • Chief Medical Officer

    June, 2019 - present

  • Managing Clinical Director

    December, 2018

View in org chart